This content is from: Patents

Pharma IP Summit: China’s patent linkage system losing steam

A lack of policy direction and timeline on patent linkage is creating industry doubts, but some believe that China shouldn’t rush it forward

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial